A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)
Clinical trial NCT05540860 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05540860
- Sponsor
- Edgewise Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-24
- Primary completion
- 2027-01-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.